P4 Precision Medicine Accelerator

🚀 Exciting Opportunity Alert! 🚀 Attention to all UK-based MedTech innovators! Are you seeking to advance your revolutionary medical technology to the next stage? The MedTech Venture Builder (MVB) - a revolutionary 12-month programme that aims to boost your journey from concept to investment-ready venture! Led by the powerhouse collaboration of King's College London, Queen Mary University of London, City, University of London, and St George's, University of London MVB offers unparalleled support and expertise to propel your innovation forward. You can expect: ✅ Strategic milestone development ✅ Regulatory guidance ✅ Access to Quality Management System ✅ Investor engagement opportunities ✅ Ongoing post-programme support Plus, selected ventures receive £20,000 grant funding and space at London Institute for Healthcare Engineering Don't miss out on this unique opportunity to transform your MedTech vision into reality. Apply now (tiny.cc/j5soxz) and join us on the journey of innovation and impact! Applications close on May 21st, so act fast! #MedTech #Innovation #VentureBuilder #Healthcare #UKTech 🚀💡 Nathan McNally

Are you a scaling growing company looking to explore new markets? P4's mission to is to break down the barrier for precision medicine companies to scale and one barrier we have seen with our alumni and experience over the years is showing global applicability and entering new markets where understanding and early interaction/conversations are key. P4 is continuing to build the ecosystem globally and if you are interested in exploring new markets, visiting and meeting potential partners physically and gaining traction and validation, then we welcome you signing up your interest below. https://lnkd.in/ecbSQxcG P4 Precision Medicine Accelerator @globaltechIP Department for Business and Trade

Happy International Women's Day. Firstly to celebrate our great team, founders and great women's health innovations we have worked with and supported over the years and the ecosystem that has supported them across the journey. Jane Osborne-Buglear Julie Devonshire OBE Sally Bennett MBChB, CertIoD Neelam Patel Katerina Sanchez-Schilling Dina Molnar Lorraine Brown Loraine D. Cansu Deniz Bayrak Pilar Fernandez Hermida Brodie T. Georgina Rizik, MBA Rebecca Brown Laurel Ye Narges Amini Marija Butkovic Priya Oberoi Jen Estherby Uzma Choudry, Ph.D Ala Alenazi Riam Kanso - As well as all the other great women leaders, advisors and mentors. According to a Department of health and social care women want the health system to focus on: - Gynaecological conditions (63%) - Fertility, pregnancy, pregnancy loss and postnatal support (55%) - Menopause (48%) - Menstrual health (47%) - Mental health (39%) #internationalwomensday #womensday2024 #iwd2024

Precisio Biotix Therapeutics Acquires (P41) P4 2019 Alumni CC Bio. P4 Precision Medicine Accelerator Nathan McNally and the team are delighted for Matthew Cummings David Corcoran and the CC Bio team for what they have achieved.

Thank you Manish! P4 continues to support our companies across their journey as you open up for your series A it’s a pleasure setting up meetings for further funding rounds.

🎉 Congratulations to GlycanAge on securing €3.9 million in seed funding! 🚀 Thrilled to see the success of GlycanAge, a biotech startup pioneering personalised preventative healthcare through glycan biomarkers. As part of our P4SY accelerator programme where we ran a regional focused P4 programme to foster innovation and adoption in the South Yorkshire region, we've witnessed firsthand their dedication and innovation. Under the visionary leadership of CEO Nikolina Lauc and Chief Scientific Officer Dr. Gordan Lauc, GlycanAge is revolutionising healthcare with cutting-edge technology and scientific expertise. This funding milestone is a testament to their hard work and commitment to advancing glycomics and precision medicine. Excited to continue supporting GlycanAge on their journey to redefine healthcare. Here's to a future where healthcare is proactive, personalised, and accessible to all! https://lnkd.in/eBz8X-Hp 🌟 #HealthcareInnovation #PreventativeHealthcare #GlycanAge #SeedFundingSuccess 🌱💼

P4 Precision Medicine Accelerator has over 80+ mentors in the ecosystem plus over 500 organisations and 200 alumni that are on the same journey to pass on their experience. The strength of P4 is the network that is ever expanding. To gain support for your start up apply for 2024. Apply Now https://lnkd.in/g9gErAz

Vinehealth acquired by Sciensus Acquiring Vinehealth has given Sciensus an instant boost to our digital and patient support capabilities. Vinehealth, the innovative cancer health tech business, is a ground-breaking patient app and physician support platform used by both patients and physicians. This exciting move allows us to expand our industry-leading portfolio of digital insight solutions, which encompasses a range of apps and portals, helping patients to make the most out of their medicine. The addition of Vinehealth will further engage and empower patients, whilst providing greater visibility of their treatment plans and care. This will lead to more personal clinical care, and ultimately, better health outcomes for patients. https://lnkd.in/eRuzezyt

Are you raising the next round of investment? Joining the P4 Precision Medicine Accelerator programme supports in hitting the next milestones and accessing the investor network for that next round of funding. Apply now at https://lnkd.in/g9gErAz Our companies have raised from the likes of: Octopus Ventures Seedcamp KHP Ventures AlbionVC Pentech Ventures Beacon Venture Capital Connect Ventures Techstars Entrepreneur First Hoxton Ventures Crista Galli Ventures SOSV Funding London (LCIF) SFC Capital Mustard Seed CMS Ventures Playfair Ascension Cambridge Angels Tiny Ventures Talis Capital Crowdcube R42 Group LocalGlobe InHealth Ventures SyndicateRoom 7percent Ventures Speedinvest Mercia Capital Partners Ada Ventures Apollo Health Ventures

P4 seeks the world's best innovations that fit with one of the 4 Ps of personalised medicine! P4 has supported spinouts, IP based start-ups or founders from UK universities from across the country. With over 200+ companies supported, raising over £200m+ private investment and £50m+ of public funding from translation, regulation to commercialisation together with raising further investment, P4 is looking for the next cohort for 2024! Are you spinning out or a spin-out from a University looking for support to navigate the journey of milestones and the next round of funding does your innovation make medicine more: 🙎♂️ Personalised 📍 Precise 💊 Preventative 🗒 Participatory if so apply at https://lnkd.in/g9gErAz